Anti-staining Efficacy of Anti-Discoloration System (ADS) Added to Chlorhexidine (CHX)
Launched by UNIVERSITY OF MILAN · Mar 11, 2016
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
In the first phase, the "immediate" objective and subjective evaluation of dental discoloration by spectroscopic (CIE L\*a\*b\* data analysis with DeltaE evaluation) and questionnaire-based analyses will be recorded. Immediate visual analysis of tooth pigmentation will be evaluated by volunteer him/herself, using a mirror, and by a single dentist soon after the end of each treatment. Participants will indicate the presence/absence of dental pigmentation, and to quantify it with a numeric scale (0= no pigmentation to 10= very strong pigmentation).
These analyses will be performed at baselin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • to be free from oral mucosa conditions affecting its integrity
- • to avoid drug or mouthwash intake during the study and in the previous month
- Exclusion Criteria:
- • specific allergy to mouthrinses
- • presence of periodontitis
- • frequent use of Chlorhexidine-based oral hygiene products
About University Of Milan
The University of Milan is a prestigious academic institution renowned for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively sponsors clinical trials aimed at enhancing healthcare outcomes and fostering innovation in medical science. Its research initiatives are guided by a dedication to ethical standards and rigorous scientific methodologies, ensuring that trials not only contribute to the body of knowledge but also prioritize patient safety and well-being. Through its extensive network of researchers and clinicians, the University of Milan plays a pivotal role in translating scientific discoveries into practical applications that benefit communities both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Milano, , Italy
Patients applied
Trial Officials
Antonio Carrassi, MD
Principal Investigator
University of Milan
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials